The U.S. House of Representatives and the U.S. Senate introduced the Health Equity and Accountability Act (HEAA) of 2024, which provides a comprehensive set of strategic policy solutions designed to enhance the health and well-being of underserved and marginalized communities.
The Senate Committee on Health, Education, Labor and Pensions will hold a hearing this morning on addressing medical debt.
Today, the House Appropriations Subcommittee on Labor Health and Human Services considered and approved its draft FY25 appropriations bill that includes increases for federal cancer research funding at the National Cancer Institute (NCI).
Tomorrow, the U.S. House Committee on Ways and Means is expected to mark up the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act.
Today, the U.S. Court of Appeals for the Fifth Circuit partially reversed a district court decision that had invalidated key provisions of the Affordable Care Act (ACA) in the case of Braidwood v. Becerra, finding cost-free preventive services could remain in place...
Today, the Food and Drug Administration (FDA) dealt a blow to public health by authorizing the sale of four menthol e-cigarettes manufactured by NJOY LLC.
The Consumer Financial Protection Bureau (CFPB) released a proposed rule today to lessen the impact of medical debt on an individual’s credit.
Today, the American Cancer Society Cancer Action Network was joined by 51 other organizations in a letter asking Congress to swiftly pass the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act.
ACS CAN released two reports today which provide a snapshot of utilization management requirements for specific cancer drugs in both the Medicare Part D plans and Medicare Advantage plans with drug coverage.
Un proyecto de legislación federal facilitaría la participación de todos los pacientes con cáncer en ensayos clínicos. Patrocinada por los representantes Raúl Ruiz (D-Calif.) y Larry Bucshon (R-Ind.), la Ley de Modernización de Ensayos Clínicos (Clinical Trial Modernization Act, en inglés) es una legislación bipartidista que aumentaría el acceso a los ensayos clínicos, ya que ayudaría a eliminar las limitaciones económicas y geográficas que impiden la participación de los pacientes.